- Genmab (GE9 TH) +7%
- Genmab, AbbVie’s B-Cell Lymphoma Combo Cut Death Risk 51%
- Frontline (HF6 TH) +2.7%
- Storebrand (SKT TH) +2.7%
- Hensoldt (HAG TH) +1.9%
- Technoprobe (K8B TH) +1.6%
- Technoprobe a Leader in Growing Market, JPMorgan is Overweight
- Novo Nordisk (NOV TH) +1.5%
- Henkel (HEN3 TH) +1.5%
- Henkel Raised to Neutral at Goldman; PT 79 euros
- AT&S (AUS TH) -1.1%
- Aker BP (ARC TH) -1.1%
- Beiersdorf (BEI TH) -2.2%
- Beiersdorf Cut to Sell at Goldman; PT 73 euros
- Vend Marketplaces (XPGB TH) -2.6%
- BE Semiconductor (BSI TH) -3.4%